A large US claims analysis links out-of-pocket medication costs with adherence and discontinuation patterns among patients ...
Oregon Medical Research Center in Portland, Oregon, has led a phase 2 trial in moderate-to-severe plaque psoriasis that ...
Doctors in Noida have reported a major advance in psoriasis treatment after a young patient saw near-complete clearance of ...
The clinical-stage biotechnology company is seeking regulatory clearance to begin clinical trials of CYPS317, an allogeneic ...
A new study published in the Journal of American Medical Association showed that psoriasis patients who used antibiotics had ...
FibroBiologics submits IND application with US FDA to initiate clinical trials of CYPS317 in psoriasis patients: Houston Saturday, January 3, 2026, 11:00 Hrs [IST] FibroBiologics ...
YAG laser platform shows positive results for psoriasis: Our Bureau, Bengaluru Tuesday, December 30, 2025, 14:50 Hrs [IST] Aerolase, a US-based in ...
Researchers have uncovered a previously unrecognized role for immune cell surface sugars in driving inflammation in psoriasis. Scientists have refined how they understand the role of sugars called ...
As of Friday, January 02, Vanda Pharmaceuticals Inc.’s VNDA share price has dipped by 7.65%, which has investors questioning ...
FibroBiologics is pursuing a development program for CYPS317 with the goal of advancing first-in-human clinical trials following FDA review of the IND filing. The IND submission includes comprehensive ...
inews.co.uk on MSN
The good health news that could improve your life in 2026
Medical progress has led to breakthroughs that could help people at every stage of life, from the smallest babies to the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback